Schedule 13G ownership disclosure
HEPION PHARMACEUTICALS INC
Common Stock, par value $0.0001 per share · CUSIP: 426897104
Event date: 2025-08-14
- Filing-level shares
- 0.00
- Percent of class
- 0%
- S.H.N. Financial Investments Ltd.
Shares: 0.00 · Class: 0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001079973-25-001303
- Form type
- SCHEDULE 13G/A
- Filer
- Hepion Pharmaceuticals, Inc.
- CIK
- CIK 1583771
- Filed
- Aug 14, 2025
- Reporting period
- Aug 14, 2025
- Description
- Schedule 13G beneficial ownership